|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4560495 |
| 003 |
ICU |
| 005 |
20031020232000.0 |
| 008 |
010806s2001 ne a b 001 0 eng c |
| 010 |
|
|
|a 2001040793
|
| 020 |
|
|
|a 0444509046 (hardcover : alk. paper)
|
| 035 |
|
|
|a 2001040793
|
| 035 |
|
|
|a (DNLM)101124911
|
| 040 |
|
|
|a DNLM
|c DNLM
|d DLC
|d NhCcYBP
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC641
|b .A495 2001
|
| 060 |
1 |
0 |
|a W1
|b EU7307 v.6 2001
|
| 060 |
1 |
0 |
|a QZ 200
|b A5316 2001
|
| 082 |
0 |
0 |
|a 616.1/52
|2 21
|
| 245 |
0 |
0 |
|a Anaemia in cancer /
|c edited by Carsten Bokemeyer, Heinz Ludwig.
|
| 250 |
|
|
|a 1st ed.
|
| 260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier,
|c 2001.
|
| 300 |
|
|
|a viii, 227 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a European School of Oncology scientific updates ;
|v v. 6
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Introduction /
|r C. Bokemeyer and H. Ludwig --
|t Erythropoiesis and anaemia /
|r P. Beris --
|t Anaemia in patients with cancer: An overview /
|r T. Mughal --
|t Pathophysiology of anaemia in cancer /
|r M. R. Nowrousian --
|t Causes of anaemia in cancer patients with emphasis on treatment factors /
|r C. Bokemeyer --
|t Measuring quality of life in the anaemic cancer patient /
|r A. Bottomley --
|t Anaemia and organ function: Pathophysiological changes associated with low haemoglobin levels /
|r C. Bokemeyer --
|t The use of allogeneic blood transfusions in cancer surgery /
|r F. Mercuriali and G. Inghilleri --
|t Strategies to reduce blood transfusions in cancer therapy /
|r F. Mercuriali and G. Inghilleri --
|t EPO: gene, molecule and receptor /
|r P. Beris --
|t Overview of clinical trials on rHuEPO in cancer patients /
|r H. Ludwig and E. Fritz --
|t rHuEPO and quality of life in cancer-related anaemia /
|r A. Bottomley --
|t Prediction of response to rHuEPO /
|r Y. Beguin --
|t The use of rHuEPO in cancer patients: practical issues /
|r C. Bokemeyer and H. Ludwig --
|t Tumour oxygenation and treatment outcome /
|r M. Molls --
|t Pharmacoeconomic analyses of the use of rHuEPO in chemotherapy-induced anaemia of cancer patients /
|r N. Neymark --
|t Novel treatments for cancer-related anaemia /
|r M. S. Gordon.
|
| 650 |
|
0 |
|a Anemia.
|0 http://id.loc.gov/authorities/subjects/sh85004940
|
| 650 |
|
0 |
|a Cancer
|x Complications.
|0 http://id.loc.gov/authorities/subjects/sh85019500
|
| 650 |
|
0 |
|a Recombinant erythropoietin
|x Therapeutic use.
|
| 650 |
1 |
2 |
|a Neoplasms
|x complications.
|
| 650 |
2 |
2 |
|a Anemia
|x etiology.
|
| 650 |
2 |
2 |
|a Anemia
|x therapy.
|
| 650 |
|
7 |
|a Anemia.
|2 fast
|0 http://id.worldcat.org/fast/fst00808617
|
| 650 |
|
7 |
|a Cancer
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst00845337
|
| 650 |
|
7 |
|a Recombinant erythropoietin
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst01091490
|
| 700 |
1 |
|
|a Bokemeyer, C.
|q (Carsten)
|0 http://id.loc.gov/authorities/names/n97803517
|1 http://viaf.org/viaf/66608624
|
| 700 |
1 |
|
|a Ludwig, H.
|q (Heinz)
|0 http://id.loc.gov/authorities/names/n81002655
|1 http://viaf.org/viaf/40686862
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)47756537
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 7b9f74cb-939d-5321-bb6c-3f0f19fbac2e
|s 2e5b179f-f0b7-5f74-a5d1-aaa4f0b478a8
|
| 928 |
|
|
|t Library of Congress classification
|a RC641 .A495 2001
|l ASR
|c ASR-SciASR
|i 4531785
|
| 927 |
|
|
|t Library of Congress classification
|a RC641 .A495 2001
|l ASR
|c ASR-SciASR
|e BERE
|e CRERAR
|b 60051056
|i 7172435
|
